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Objectives: Long noncoding RNAs (lncRNAs) have emerged as a novel class of regulatory molecules
involved in various biological processes, but their role in osteoarthritis (OA) remains unknown. There-
fore, we aimed to reveal lncRNAs expression proﬁle in human osteoarthritic cartilage and explore the
potential functions of lncRNAs in OA.
Methods: The expression proﬁles of lncRNAs and mRNAs in OA cartilage were obtained using microarray
and veriﬁed by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Bioinformatics
analyses including lncRNA classiﬁcation and subgroup analysis, gene ontology (GO) analysis, pathway
analysis, network analysis and target prediction were performed.
Results: There were 3007 upregulated lncRNAs and 1707 downregulated lncRNAs in OA cartilage
compared with normal samples (Fold change  2.0). In addition, 2136 mRNAs were upregulated and
2,241 mRNAs were downregulated in OA cartilage (Fold change  2.0). The qRT-PCR results of six dys-
regulated lncRNAs were consistent with the microarray data. 106 lncRNAs and 291 mRNAs composed the
coding-non-coding gene co-expression network (CNC network). In the 600 top differentially expressed
lncRNAs, 48 lncRNAs were predicted to have more than ﬁve cis-regulated target genes and up to 530
lncRNAs might regulate their trans target genes through collaboration with transcriptional factor (TF)
SP1. The positive correlation between lncRNA uc.343 and predicted target homeobox gene C8 (HOXC8)
expression in SW1353 cells treating with interleukin-1 beta conﬁrmed the target prediction to some
extent.
Conclusions: This study revealed the expression pattern of lncRNAs in OA cartilage and predicted the
potential function and targets, which indicated that lncRNAs may be new biomarkers for diagnosis or
novel therapeutic targets of OA.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a widespread chronic joint disorder that
frequently results in joint pain, joint dysfunction, and disability1.
The lifetime risk of suffering fromOA is 25% for symptomatic hip OA
and 44.7% for symptomatic knee OA, making the knee the most
commonly affected joint2,3.Z. Zhang, Department of Or-
t-sen University, #58 Zhong-
8775-5766; Fax: 86-20-8733-
y to this study.
ternational. Published by Elsevier LOA is thought to be a multifactorial disease. In addition to the
traditional risk factors such as joint instability, aging and obesity,
genetic links to OA susceptibility have been observed in twin
studies and family groups4,5. Epigenetic effects including histone
modiﬁcations, DNA methylation, and noncoding RNAs likely
contribute to OA6. Particularly, noncoding RNAs have been shown
to play an important role in the processes of bone and cartilage
development7.
Noncoding RNAs can be classiﬁed into two major groups based
on their length, short noncoding RNAs and long noncoding RNAs
(lncRNAs). MicroRNAs, themost-studied short noncoding RNAs, are
differentially expressed in osteoarthritic and normal cartilage. For
example, in osteoarthritic cartilage, miR-9 is upregulated8, while
the expression of miR-27a, miR-140, and miR-146 are
decreased8e11. We also showed previously the speciﬁc expressiontd. All rights reserved.
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miR-193b, miR-92b12. In addition, several microRNAs have been
investigated in vitro and in vivo to clarify their potential role in the
genesis and development of OA13,14.
Recently, a great deal of attention has been paid to a novel class
of noncoding RNAs, called lncRNAs, which are mRNA-like and over
200 nucleotides in length. LncRNAs are known to be pervasively
transcribed in mammalian genomes15. Increasing amounts of evi-
dence implicate lncRNAs in a number of regulatory processes
where they serve as signals, decoys, guides, and scaffolds16,17.
LncRNAs may also have important effects on both normal devel-
opment and disease7. Previous work suggests that lncRNAs are
differentially expressed in many human diseases such as cancer,
metabolic disease, cardiovascular disease, neurodegenerative dis-
ease, and psychiatric disease18. For example, the lncRNA termed
HOTAIR was upregulated in breast tumors and promoted cancer
invasiveness and metastasis through reprograming chromatin
state19. However, very rare study addresses lncRNA expression and
function in cartilage development and degeneration. Some re-
searchers reported that a number of lncRNAs were aberrantly
expressed in OA cartilage compared to normal sample and one ofFig. 1. LncRNA proﬁle of microarray data. (A). Scatter-Plot of lncRNA expression. The lncRNAs
change of lncRNAs between OA cartilage and control normal samples. (B). Volcano Plot of the
expressed lncRNAs with statistical signiﬁcance. (C). Hierarchical Clustering shows a disting
groups. RNA was extracted from cartilage samples obtained from six OA patients and ﬁve cthose, lncRNA-CIR, contributed to degeneration of chondrocyte
extracellular matrix in vitro20. But the overall features of lncRNAs
expression proﬁle and their potential biological functions in OA are
still unclear.
In this study, we compared the expression proﬁle of lncRNAs in
cartilage from knee OA patients to normal cartilage from control
subjects at the microarray level. Several of the differentially
expressed lncRNAs were validated using quantitative reverse
transcription polymerase chain reaction (qRT-PCR). Moreover,
lncRNA classiﬁcation and subgroup analysis was performed to
explore the potential function of the differentially expressed
lncRNAs and the potential targets of some differentially expressed
lncRNAs were predicted.
Materials and methods
Patient samples
This study was approved by the Ethics Committee of The First
Afﬁliated Hospital of Sun Yat-sen University, China (IRB. [2012]040)
and performed in accordance with the Declaration of Helsinki. Allabove the top green line and below the bottom green line indicated more than 2.0 fold
differentially expressed lncRNAs. The red points in the plot represent the differentially
uishable lncRNA expression proﬁle between the two groups and homogeneity within
ontrol subjects.
M. Fu et al. / Osteoarthritis and Cartilage 23 (2015) 423e432 425participants gave their informed consent. Osteoarthritic cartilage
with obvious erosion was obtained from knee OA patients (n ¼ 6,
one men and ﬁve women, age range 57e77 years) undergoing total
knee arthroplasty. Normal cartilage without gross sign of degra-
dation was collected from control subjects (n ¼ 5, three men and
two women, age range 10e17 years) with no history of OA or
rheumatoid arthritis who underwent amputation resulting from
osteosarcoma. All cartilage samples were harvested from tibia
plateau or femoral condyle. Each sample was dissected into two
portions: one was used for microarray and the other for qRT-PCR.
All samples were preserved in liquid nitrogen until use.
Cell culture and treatments
Human chondrogenic SW1353 cells were maintained in Leibo-
vitz's L-15 Medium (Gibco, NY, USA) containing 10% fetal bovine
serum (Gibco) and 1% penicillin/streptomycin (Gibco). During the
culture period, cells were incubated at 37C in a humidiﬁed at-
mosphere of 100% air and the medium was replaced every 2e3
days. After 24 h of serum starvation, cells were treated with 10 ng/
ml recombinant human interleukin-1 beta (IL-1b) (PeproTech, NJ,
USA) for 4 h, 12 h and 24 h. Cells were harvested for subsequent
experiments.
RNA extraction
Total RNA was extracted from each cartilage sample and cell
culture using TRIzol (Invitrogen, Carlsbad, CA, USA) per the man-
ufacturer's protocol. RNA quantity and quality were measured us-
ing a NanoDrop ND-1000 spectrophotometer and RNA integrity
was evaluated by standard denaturing agarose gel electrophoresis.
LncRNA array
The Human lncRNA Array v2.0 (8  60K, Arraystar) used in this
study is designed for global proﬁling of lncRNAs and protein-coding
transcripts in the human genome. Based on the authoritative da-
tabases including RefSeq, UCSC Knowngenes, RNAdb, Ensembl,
LncRNAs and many other related literature, the array can detect
33,045 lncRNAs and 30,215 coding RNAs. Each transcript is repre-
sented by a speciﬁc exon or splice junction probewhich can identify
individual transcript accurately. Negative control probes and
probes for housekeeping genes (positive controls) were also
included in the array to control the quality of hybridization.
RNA labeling and array hybridization
After removing the rRNA from the total RNA, the mRNA was
puriﬁed (mRNA-ONLYTM Eukaryotic mRNA Isolation Kit, Epi-
centre), ampliﬁed, and transcribed into ﬂuorescent cRNA along the
entire length of the transcripts using random primers to avoid 30
bias. The cRNAs were then puriﬁed using the RNAeasy Mini Kit
(Qiagen). The concentration and speciﬁc activity of the labeled
cRNAs (pmol Cy3/mg) were measured with the NanoDrop ND-
1000. Then, the ﬂuorescently-labeled cRNAs were hybridized
onto the Human lncRNA Array following the Agilent One-Color
Microarray-Based Gene Expression Analysis protocol (Agilent
Technology) with minor modiﬁcations. Brieﬂy, a mixture con-
taining 1 mg of labeled cRNA, 5 mL 10 Blocking Agent, and 1 mL of
25 Fragmentation Buffer was heated at 60C for 30 min to
fragment the cRNAs. Then the labeled cRNA was diluted using
25 mL 2 GE Hybridization buffer. 50 mL of the cRNA in hybridi-
zation buffer was dispensed into a gasket slide and assembled on
the lncRNA expression microarray slide. The slides were incubated
at 65C for 17 h in an Agilent Hybridization Oven. Finally, the arraywas washed and scanned using the Agilent DNA Microarray
Scanner (part number G2505C).
Computational analysis
Agilent Feature Extraction software (version 11.0.1.1) was used
to analyze the acquired array images. The raw data was quantile
normalized, and lncRNAs and mRNAs that were ﬂagged as present
or marginal (“all targets value”) in at least three out of 11 samples
were chosen for further data analysis with the GeneSpring GX
v11.5.1 software package (Agilent Technologies). Volcano plot
ﬁltering was used to identify lncRNAs and mRNAs with statistically
signiﬁcant differences in expression. Hierarchical Clustering was
applied to present the diacritical lncRNA and mRNA expression
patterns among the samples. LncRNA classiﬁcation and subgroup
analysis was carried out to explore the potential function of the
differentially expressed lncRNAs. Gene ontology (GO) analysis and
pathway analyses were also performed to describe more fully the
roles of the differentially expressed mRNAs. Furthermore, a coding-
non-coding gene co-expression network (CNC network) was drawn
using Cytoscape with Pearson coefﬁcient (jrj) > 0.995. The micro-
array analysis was performed by KangChen Bio-tech, Shanghai, PR
China.
qRT-PCR
Total RNA was reverse-transcribed to cDNA using Super-
ScriptTM III Reverse Transcriptase (Invitrogen) according to the
manufacturer's instructions. The qRT-PCR primers were designed
using Primer 5.0 and blasted for speciﬁcity in NCBI (Table S1).
qRT-PCR was performed using 2 SYBR Green PCR Master Mix
(Arraystar) on an Applied BiosystemsViiA 7 Real-time PCR Sys-
tem. The ﬁnal reaction volume was 10 mL and contained 5 mL of
SYBR Green PCR Master Mix (2), 0.5 mL of the forward and
reverse primers (10 mM), 2 mL of cDNA, and 2 mL of double-
distilled water. The qRT-PCR reaction conditions were: denatur-
ation at 95C for 10 min, followed by 40 cycles of 95C for 10 s,
and 60C for 60 s. The results were normalized to U6 or GAPDH
expression to obtain DCt values. Fold changes in expression were
calculated using the 2DDCt method. All experiments were per-
formed in triplicate.
Target prediction
The top 300 upregulated and 300 downregulated lncRNAs
were selected for target prediction. For each lncRNA, we calcu-
lated the Pearson Correlation of its expression value with that of
each mRNA. mRNAs that were co-expressed with the lncRNA of
interest were deﬁned as having a Pearson Correlation that
exceeded 0.8 and a P Value less than 0.0515. We identiﬁed the
mRNAs as “cis-regulated target genes” when: (1) the mRNA loci
were within a 300 kb window up- or downstream of the given
lncRNA and (2) the Pearson correlation of lncRNA-mRNA expres-
sion was signiﬁcant (P-value < 0.01). We then determined which
mRNA was likely trans-regulated by the lncRNA of interest. For
each lncRNA, we calculated the overlap of the co-expressed mRNA
set with transcriptional factor (TF) target genes and used hyper
geometric distribution to calculate the signiﬁcance of this overlap.
If the mRNAs co-expressed with a given lncRNA signiﬁcantly
overlapped with the target genes of a given TF, it suggested that
this TF might interact with the lncRNA and these mRNA might be
the trans-regulated target genes of the lncRNA21. We used TF
target sets identiﬁed by the Encyclopedia of DNA Elements
(ENCODE)22. All the calculations were performed in the Matlab
environment.
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For microarray analysis and qRT-PCR validation, signiﬁcance of
differences in expression levels between OA and control groups
was evaluated with unpaired t-test. For GO and pathway analysis,
Fisher's exact test was used to evaluate signiﬁcance of GO terms or
Pathway identiﬁers enrichment in the differentially expressed
genes. For CNC network construction and target prediction, Pearson
productemoment correlation coefﬁcient was utilized to test the
correlation between expression of lncRNA and co-expressedmRNA.
In addition, one-way analysis of variance (ANOVA) followed by
Dunnett-t test was used for comparison in multiple groups in cell
experiments. Analysis was performed in SPSS (Version 13.0, SPSS
Inc.) and a value of P < 0.05 was considered statistically signiﬁcant.Results
Differentially expressed lncRNAs
We identiﬁed 15,099 lncRNAs expressed in OA cartilage and
3007were upregulated and 1707 were downregulated signiﬁcantly
when compared to healthy tissue (fold change 2.0, P value < 0.05)
[Fig. 1(AeB), Table S2]. Of these, 30 of the upregulated lncRNAs and
92 downregulated lncRNAs were more than 6.0 different from the
healthy tissue. The lncRNA that was most upregulated was
NR_001564 (Fold change: 70.95505596), and the most down-
regulated was NR_001543 (Fold change: 25.36789788) (Table I). In
general, upregulated lncRNAs were more common than down-
regulated ones in our microarray data. However, there were more
markedly downregulated lncRNAs (Fold change  6.0) than upre-
gulated ones. Hierarchical clustering analysis indicated distin-
guishable lncRNA expression proﬁles between the samples and
homogeneity within groups [Fig. 1(C)].Table I
Top 15 differentially expressed lncRNAs (OA vs Normal)
lncRNA seqname Regulation Type
NR_001564 Up Intergeni
ENST00000421322 Up Intergeni
AK054860 Up Intergeni
ENST00000419932 Up Intergeni
ENST00000362552 Up Intergeni
AL359062 Up Intergeni
BX096395 Up Intergeni
ENST00000451488 Up Intronic a
ENST00000492517 Up Intergeni
chr8:20578220-20590170þ Up Intergeni
BI015463 Up Intergeni
uc003ijt.2 Up Intergeni
uc.277- Up Intronic a
AL832767 Up Natural a
ENST00000435108 Up Bidirectio
NR_001543 Down Intron sen
AK289744 Down Exon sen
ENST00000414488 Down Intergeni
AL137603 Down Exon sen
ENST00000446763 Down Intergeni
ENST00000433698 Down Intergeni
NR_027335 Down Natural a
ENST00000493817 Down Intergeni
ENST00000393516 Down Intergeni
BQ045000 Down Exon sen
ENST00000376781 Down Intronic a
exon1961- Down Intergeni
ENST00000419698 Down Intergeni
ENST00000429037 Down Intergeni
ENST00000399021 Down IntergeniLncRNA classiﬁcation and subgroup analysis
We next performed analyses based on the lncRNA subgroups.
There were 126 lncRNAs with enhancer-like functions that were
found to be differentially expressed, and the nearby coding RNAs
were identiﬁed23 (Table S3). In addition, the probes used to proﬁle
the HOX cluster covered all four HOX loci and targeted 407 discrete
transcribed regions, lncRNAs, and coding transcripts24. In our data,
329 lncRNAs and 167 coding transcripts were deregulated in OA
cartilage (Table S4). Furthermore, based on previous work22, we
identiﬁed 282 differentially expressed long intergenic non-coding
RNAs (lincRNAs) and the nearby coding RNAs (distance <300 kb)
that were deregulated (Table S5).
Differentially expressed mRNAs
When compared to normal cartilage, 2136 mRNAs were upre-
gulated and 2241 mRNAs were downregulated in OA cartilage (Fold
change  2.0, P value < 0.05) [Fig. 2, Table S6]. Of these, COL1A2
(Collagen, type 2, alpha 2) (upregulated) and RPS4Y1 (Ribosomal
protein S4, Y-linked 1) (downregulated) were themost signiﬁcantly
deregulated mRNAs (Table II).
GO analysis and pathway analysis
In terms of GO, upregulated transcripts were highly enriched for
anatomical structure development (ontology: biological process),
cell periphery (ontology: cellular component), and lipid binding
(ontology: molecular function). The downregulated transcripts
were highly enriched for cellular metabolic processes (ontology:
biological process), intracellular parts (ontology: cellular compo-
nent), and RNA binding (ontology: molecular function) (Fig. S1).
Pathway analysis showed that 26 pathways corresponded to
downregulated transcripts, but the pathway for “Huntington'sFold change P-value
c 70.95505596 0.020537948
c 32.71040885 0.002264769
c 26.94639517 0.010597968
c 16.3758879 0.000893483
c 12.23468501 0.004721541
c 10.50978851 0.001523151
c 10.06217095 4.98291E-05
ntisense 9.670881385 0.001760138
c 7.575699751 0.010164413
c 7.425674499 0.005828284
c 7.401797723 0.001286045
c 7.275065178 0.003444891
ntisense 7.178948377 0.002318289
ntisense 7.075295663 0.005126601
nal 6.741386995 0.004704847
se-overlapping 25.36789788 0.036850063
se-overlapping 21.26838374 0.000158653
c 18.81553126 1.00315E-06
se-overlapping 15.65188127 5.24334E-05
c 11.71348417 0.022028764
c 11.48912362 0.000577364
ntisense 11.38558428 0.000367825
c 10.52423284 0.008465700
c 10.48102555 0.003681505
se-overlapping 10.19282905 0.004996498
ntisense 9.478012082 8.08828E-05
c 9.319754056 0.009895113
c 9.210951846 0.006133519
c 9.110173122 0.007236367
c 8.678029257 0.006566619
Fig. 2. mRNA proﬁle of microarray data. (A). Scatter-Plot of mRNA expression. The mRNAs above the top green line and below the bottom green line indicated more than 2.0 fold
change of mRNAs between OA cartilage and control normal samples. (B). Volcano Plot of the differentially expressed mRNAs. The red points in the plot represent the differentially
expressed mRNAs with statistical signiﬁcance. (C). Hierarchical Clustering shows a distinguishable mRNA expression proﬁle between the two groups and homogeneity within
groups. RNA was extracted from cartilage samples obtained from six OA patients and ﬁve control subjects.
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upregulated transcripts, there were 21 pathways represented and
the most highly enriched was the “calcium-signaling pathway”
(Fig. S2B). In particular, the Wnt signaling pathway which was
associated with upregulated transcripts, has been shown to be
involved in cartilage degeneration25 (Fig. S2C).
Construction of CNC network
Based on the strength of the correlation between the differen-
tially expressed mRNAs and lncRNAs, a CNC network was con-
structed (Fig. S3). LncRNAs and mRNAs with Pearson correlation
coefﬁcients that exceeded 0.995 were selected to draw the
network. There were 106 lncRNAs and 291 mRNAs that composed
the CNC network nodes and 1647 network pairs were made.
Interestingly, these network pairs all presented as positive. In this
co-expression network, a single lncRNA could correlate with many
mRNAs and vice versa. Meanwhile, among these network pairs,
therewere also some correlations between several top lncRNAs andtop mRNAs. For instance, lncRNA-ENST00000492517 (fold change:
7.575699751) and mRNA-RASGEF1B (RasGEF domain family,
member 1B; fold change: 4.724045314) were predicted to co-
express with a 0.997 Pearson correlation coefﬁcients. And both of
them are one of the top 100 lncRNAs and mRNAs respectively.qRT-PCR validation
To conﬁrm the reliability of our microarray data, we randomly
selected three upregulated lncRNAs (lincRNA-THBS2-1, RP11-
195E11.3, RP11-632K21.1) and three downregulated lncRNAs
(lincRNA-SUN2, RP11-396J17.1, AP003175.1) from the pool of
lncRNAs whose fold changes were >6.0, and analyzed their
expression levels by qRT-PCR in eleven cartilage samples (six
degenerative and ﬁve normal samples, which were obtained from
the same subjects used for microarray). The qRT-PCR results were
consistent with themicroarray data and showed the same trends of
up- or downregulation for each lncRNA (Fig. 3).
Table II
Top 15 differentially expressed mRNAs (OA vs Normal)
Gene symbol Seqname Regulation Fold change P-value
COL1A2 NM_000089 Up 29.26053156 0.001002816
GREM1 NM_013372 Up 15.37760665 0.036073329
SOX11 NM_003108 Up 13.64402769 7.13094E-05
TNFAIP6 NM_007115 Up 11.61621176 0.002637703
CRLF1 NM_004750 Up 10.65717056 0.000709821
LRRC15 NM_001135057 Up 10.50432032 0.001798242
S100A4 NM_019554 Up 10.21520041 1.0907E-05
POSTN NM_001135936 Up 9.474713899 0.000737562
AQP1 NM_198098 Up 9.364518738 0.003479368
MXRA5 NM_015419 Up 9.008914977 5.75683E-06
IGFBP4 NM_001552 Up 8.936242192 0.001155883
NEFH NM_021076 Up 8.824697202 0.000112711
EDN1 NM_001168319 Up 8.755084907 0.005245719
AMTN NM_212557 Up 7.979077026 0.001293727
ZNF547 NM_173631 Up 7.615528923 0.000364084
RPS4Y1 NM_001008 Down 30.08509332 5.01605E-05
C10orf10 NM_007021 Down 17.85702738 0.003803867
GSTT1 NM_000853 Down 15.91570884 0.039902322
GPX3 NM_002084 Down 12.05533469 0.000300364
SPINT2 NM_001166103 Down 11.11424554 0.003183241
RPL17 NM_000985 Down 10.86206470 0.006256300
GCOM1 NM_001018100 Down 10.71062851 0.016264241
APOD NM_001647 Down 9.552392829 0.022232575
SLC43A2 NM_152346 Down 9.534019988 0.005842296
GCHFR NM_005258 Down 8.985986182 1.60103E-05
CD7 NM_006137 Down 8.982644468 0.001624822
GPR137 NM_001170880 Down 8.936949363 0.032756832
ACAN NM_001135 Down 8.702298878 0.000382744
HIST1H2BG NM_003518 Down 8.693138721 0.002659843
TRAP1 NM_016292 Down 8.636292063 0.000279428
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To explore how lncRNAs might participate in regulating carti-
lage degeneration, we attempted to predict the cis- and trans-
regulated target genes of the 600 top differentially expressed
lncRNAs. There were 48 lncRNAs that were predicted to have more
than ﬁve cis-regulated target genes, some of which are reportedly
involved in the development or degeneration of cartilage (Table S7).
For instance, homeobox gene C8 (HOXC8) and secreted phospho-
protein 1 (SPP1) were predicted to be the cis-regulated target genes
of the upregulated lncRNA uc.343 (fold change: 4.210282788) and
the downregulated lncRNA HSP90AA4P (fold change: 4.155568978)
respectively (Fig. 4). In terms of trans-regulated target genes, up toFig. 3. Comparison of lncRNAs expression level between microarray and qRT-PCR results
validated by qRT-PCR in cartilage samples from six OA patients and ﬁve normal control su
expression and calculated by 2DDCt method. The heights of the columns in the chart represe
The qRT-PCR results are consistent with microarray data. ***P < 0.001 vs normal group in530 lncRNAs were co-expressed with coding genes that are target
genes for the TF SP1, which is vital for the development and
degeneration of cartilage (Table S8). These co-expressed coding
genes were identiﬁed as trans-regulated target genes for the
differentially expressed lncRNAs. Moreover, the lncRNAs with fold
changes >6.0 and their respective trans-regulated target genes that
had the highest Pearson correlation coefﬁcients were chosen to
construct the “lncRNAs-TFs-Target Genes” network (Fig. S4,
Table III).
The positive correlation between uc.343 and HOXC8 expression in
SW1353 cells treated with IL-1b
To verify the putative target of lncRNA uc.343, we investigated
the regulation of uc.343 and predicted target HOXC8 expression by
IL-1b in SW1353 cells. SW1353 cells were stimulated with IL-1b
and the expression of uc.343, HOXC8, Collagen type 2 alpha 1
(COL2A1) and Matrix metallopeptidase 13 (MMP13) were deter-
mined by qRT-PCR. IL-1b treatment resulted in a signiﬁcant upre-
gulation of MMP13 and downregulation of COL2A1 especially at
12 h (P < 0.001) which suggested an inﬂammatory response in
SW1353 cells [Fig. 5(A)]. Expression of uc.343 and HOXC8 both was
signiﬁcantly upregulated after 12 h with IL-1b stimulation
(P < 0.01) while decreased after 24 h by IL-1b treatment without
statistical signiﬁcance (P > 0.05) [Fig. 5(B)]. Therefore, these results
suggested that there seemed to be a positive correlation between
uc.343 and HOXC8 expression in response to IL-1b.
Discussion
LncRNAs play important roles in regulating gene expression.
Abnormal expression of lncRNAs is often involved in the patho-
genesis and progression of many diseases18. A recent study
demonstrated that lncRNAs were abnormally expressed in OA
cartilage, and that a cartilage-injury related lncRNA, lncRNA-CIR,
could induce degradation of cartilage extracellular matrix
in vitro20. However, the expression pattern of lncRNA and the
classiﬁcation and subgroup of lncRNAs in cartilage remain elusive.
And the potential targets and functions of lncRNAs in terms of the
development and pathogenesis of the skeletal system are still un-
known. Therefore, in this study, we systematically screened
genome-wide expression pattern of lncRNAs as well as mRNAs in
cartilage from knee OA patients and normal subjects.. Three upregulated and three downregulated differentially expressed lncRNAs were
bjects. Each sample was analyzed in triplicate. Gene expression was normalized to U6
nt the mean fold changes (C/N) in the expression between OA group and normal group.
qRT-PCR validation.
Fig. 4. Predicted cis target genes of two differentially expressed lncRNAs (A. uc.343, B. HSP90AA4P). The X-axis represents genomic locations. The red points represent lncRNA and
the number in the bracket is the length of the lncRNA. The blue points represent possible cis target genes. The Y-axis represents Pearson correlation of lncRNA-mRNA expression.
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higher number of mRNAs displaying abnormal expression in OA
cartilage in the current study. Moreover, there were slightly more
downregulated mRNAs than upregulated ones, which was
different from the previous studies27,28. Our results broadly
conﬁrmed previously reported dysregulated mRNAs in OA carti-
lage, including Collagen type 1 alpha 1 (COL1A1), COL1A2,
Aggrecan (ACAN), MMP13, Matrix metallopeptidase 19 (MMP19),
Tumor necrosis factor, alpha-induced 6 (TNFAIP6), Periostin,
osteoblast speciﬁc factor (POSTN), Insulin-like growth factor
binding protein 4 (IGFBP4), Glutathione peroxidase 3, Thioredoxin-
interacting protein (TXNIP), TNF receptor-associated protein 1
(TRAP1) and Superoxide dismutase 2 (SOD2)26e30. However, some
genes including COL2A1, ADAM metallopeptidase with thrombo-
spondin type 1 motif 5 (ADAMTS5) and SRY (Sex determining re-
gion Y)-box 9 (SOX9), which displayed aberrant expression
previously, did not show signiﬁcant alteration in our results27,28,31.
At the same time, we also identiﬁed a number of new mRNAs with
strongly altered expression in OA cartilage such as Leucine rich
repeat containing 15 (LRRC15), Interleukin-1 receptor-associated
kinase 4 (IRAK4), CD7 molecule (CD7) and Dual speciﬁcity phos-
phatase 2 (DUSP2).
In addition to the numerous aberrantly expressed mRNAs, 122
lncRNAs that had a >6.0 fold difference in expression level between
the OA and normal cartilage were also identiﬁed. We noted that
fewer lncRNAs were deregulated in our data compared to that of
previous study20. This might be because our sample size was
slightly larger. Then several candidate lncRNAs were chosen for
qRT-PCR validation. However, expression of lncRNAs detected by
qRT-PCR showed smaller difference when comparing to microarray
results. The cause might be the vastly different normalization
procedures and other different inherent pitfalls of these two
methods32. Nonetheless, results of qRT-PCR showed the same di-
rection of regulation and statistical analysis also showed the sig-
niﬁcant differences of lncRNAs expression between OA and normalsamples. Therefore, our results of qRT-PCR conﬁrmed the micro-
array data to some extent. Moreover, using a bioinformatics
approach, we predicted that the differentially expressed lncRNAs
were likely able to execute their functions by regulating gene
expression in both a cis- and trans-fashion. And the lncRNAs
described could be involved in the degeneration of articular
cartilage.
Unlike highly conserved microRNA, it is difﬁcult to predict the
function of lncRNAs solely based on their nucleotide sequences
because they usually lack the primary sequence conservation that
leads to secondary structures33. Guttman et al. reported a bioin-
formatics method to predict the functions of lncRNAs by functional
annotation of genes that are co-expressed with the lncRNAs15.
Based on the previous work15, we developed a list of co-expressed
genes for the lncRNAs that are differentially expressed in OA based
on the correlation coefﬁcient and then derived the predictive
functions of the lncRNAs. At transcriptional level, lncRNAs were
able to regulate their targeted genes through both cis- and trans-
regulation.
Cis-regulation is identiﬁed as when the transcription of an
lncRNA affects the expressions of its neighbor genes17,34. By
screening the co-expressed genes located near the differentially
expressed lncRNAs, we discovered some possible cis-regulatory
target genes. For instance, HOXC8 might be the target of lncRNA
uc.343, which is 18 kb upstream and upregulated by 4.210282788
fold in osteoarthritic cartilage. Another example is SPP1, which is
87 kb upstream of lncRNA HSP90AA4P (4.155568978 fold down-
regulation) and a likely candidate as the cis-regulated target of
HSP90AA4P. It has been reported that HOXC8 regulated the pro-
liferation of chondrocytes by regulating cell cycles and over-
expression of HOXC8 could affect cartilage maturation and endo-
chondral ossiﬁcation35,36. In addition, SPP1, which codes for
osteopontin, could enhance the pathological mineralization of
articular cartilage. Moreover, SPP1 deﬁcient mice were prone to
developing OA37,38. Therefore, we hypothesize that lncRNAs uc.343
Table III
Differentially expressed lncRNAs collaborating with Sp1 in trans fashion
lncRNA seqname Gene symbol Regulation Type Fold change P-value
chr2:118805569-
118808550-
lincRNA-CCDC93 Up Intergenic 6.702 0.006
ENST00000435108 RP11-239E10.2 Up Bidirectional 6.741 0.005
AL832767 AL832767 Up Natural antisense 7.075 0.005
BF516116 lincRNA-TTC8 Up Exon sense-overlapping 6.435 0.000
uc.277- uc.277 Up Intronic antisense 7.179 0.002
uc003ijt.2 BC044611 Up Intergenic 7.275 0.003
ENST00000451488 RP11-195E11.3 Up Intronic antisense 9.671 0.002
uc001ﬂf.2 BC041646 Up Intergenic 6.626 0.000
ENST00000469685 CTD-2331D11.1 Down Intergenic 8.112 0.003
ENST00000493817 RP11-396J17.1 Down Intergenic 10.52 0.008
ENST00000393516 AP003175.1 Down Intergenic 10.48 0.004
ENST00000399021 RP11-464O2.5 Down Intergenic 8.678 0.007
ENST00000419698 RP11-102H24.1 Down Intergenic 9.211 0.006
Fig. 5. Gene expression changes in human chondrogenic SW1353 cells stimulated with IL-1b. SW1353 cells were treated with IL-1b for 4 h, 12 h and 24 h, and the expression of
COL2A1, MMP13 (A) and lncRNA uc.343, HOXC8 (B) was determined by qRT-PCR, compared to 0 h. Gene expression was normalized to GAPDH expression and calculated by 2DDCt
method. Values are the mean ± SD of three different experiments. Data were analyzed using one-way ANOVA followed by Dunnett-t test. **P < 0.01, ***P < 0.001 vs 0 h.
M. Fu et al. / Osteoarthritis and Cartilage 23 (2015) 423e432430and HSP90AA4P might be involved in cartilage degeneration by
regulating HOXC8 and SPP1 gene expression respectively in a cis
fashion. And we showed a positive correlation between uc.343 and
HOXC8 expression in response to IL-1b in SW1353 cells which may
provide some evidence for our prediction to some extent. But
further study is still required to conﬁrm this.
Besides, lncRNAs can also act on their target genes through long-
range trans-regulation in conjunction with other TFs. For example,
the lncRNA NRON can affect the nuclear transportation of NFAT (TF
nuclear factor of activated T cells) thereby inﬂuencing the expres-
sion of NFAT target genes39. Another lncRNA, RMST, binded with
SOX2 on some chromosome sites to regulate the expression of
neural development genes. While without RMST, SOX2 cannot
activate the transcription of its target genes. However, knocking out
either RMST or SOX2, did not have reciprocal effects on the
expression of the other gene, indicating that they act as co-
regulators for the development of nervous system40. In our study,
to discover which TFs could have co-regulatory effects with the
differentially expressed lncRNAs, we overlapped the coding genes
co-expressed with lncRNAs and the genes targeted by TFs. Inter-
estingly, 13 genes co-expressed with lncRNAs that were markedly
(>6.0 fold change in expression) different in OA cartilage were also
target genes for the TF SP1.
SP1 is a member of the SP/Kruppel family that is a group of zinc
ﬁnger TFs highly involved in eukaryotic cell transcription41. Studies
have shown that SP1 plays important roles in regulating gene
expression in chondrocytes, and mediates the biological responses
of chondrocytes to cytokines and inﬂammatory stimulation. For
example, transforming growth factor beta signaling activates SP1
through phosphorylation. Phosphorylated Sp1 then binds to tissueinhibitor of metallopeptidase 3, and induces its expression which
represses matrix metallopeptidase mediated chondrocyte degen-
eration42. In contrast, IL-1b represses the co-binding of SP1 and
SOX9 to the COL2A1 gene locus and downregulates its expres-
sion43,44. In addition, SP1 is also involved in the chondrocyte
response to biomechanical environmental stimuli. It has been
suggested that 10% dynamic pressure at 0.1 Hz can induce in vitro
expression of COL2A1 in chondrocyte culture, possibly through the
binding of SP1 to COL2A1 promoter45. And mid-level shear stress
could activate SP1 and upregulate plasminogen activator inhibitor 1
expression to enhance chondrocyte metabolism46. Thus, these
lncRNAs could possibly regulate degeneration of articular cartilage
through coordinate regulation of lncRNAs and SP1 in a trans
fashion.
There are several limitations in our study. The ﬁrst one is that
the age of control subjects was younger than the age of OA patients.
It seems that certain transcripts we detected might be age-related
rather than disease-speciﬁc. Nonetheless, the consistency of
mRNAs proﬁle between our results and the previous ﬁndings26e30
suggests that many of the differentially expressed mRNAs and
lncRNAs detected in our study are disease-speciﬁc. Moreover,
further study will be continued when more age-matched control
cartilage becomes available in the future. Another limitation is that
we merely provided some indirect experimental evidence to indi-
cate the functional link between lncRNA and its predicted target
gene, but could not presently conﬁrm the deﬁned connections
limited by the research approaches. Nevertheless, we are going to
conﬁrm our predictions of these target genes and illustrate the
functional roles of these lncRNAs in cartilage degeneration in
further research.
M. Fu et al. / Osteoarthritis and Cartilage 23 (2015) 423e432 431In summary, this study described the expression proﬁle of
lncRNAs in OA cartilage using a DNA microarray method. Bioin-
formatics approaches were used to predict the target genes and
potential functions of the differentially expressed lncRNA and
initially explore their roles in cartilage degeneration. These ﬁndings
suggested that the differentially expressed lncRNAs may serve as
new biomarkers for diagnosis of OA and novel therapeutic targets.
However, the speciﬁc molecular mechanisms and biological func-
tions of these lncRNAs in the pathogenesis of OA warrant further
exploration.
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